Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication

Journal of Gene Medicine

Volumn 3, Issue 1, 2001, Pages 51-58

  Krougliak, Valeri A ^a   Krougliak, Natalia ^a   Eisensmith, Randy C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Episomal maintenance; Epstein Barr virus (EBV); Gene therapy; Replication; Vectors

Indexed keywords

ADENOVIRIDAE; HUMAN HERPESVIRUS 4; MAMMALIA; PRIMATES;

PRIMER DNA;

ADENOVIRUS; ARTICLE; DNA REPLICATION; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TRANSGENE;

ADENOVIRIDAE; BASE SEQUENCE; DNA PRIMERS; DNA REPLICATION; GENETIC VECTORS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; TRANSGENES;

EID: 0035221344     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-2254(2000)9999:9999<::aid-jgm150>3.0.co;2-%23     Document Type: Article

References (30)

1. Chen HH, Mack LM, Kelly R, et al. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Natl Acad Sci U S A 1997; 94: 1645-1650.
2. Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A 1998; 95: 7866-7871.
3. Morsy MA, Gu MC, Zhao JZ, et al. Leptin gene therapy and daily protein administration: a comparative study in the ob/ob mouse. Gene Ther 1998; 5: 8-18.
4. Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 1998; 18: 180-183 (published erratum appears in Nat Genet 1998; 18: 298).
5. Morsy MA, Caskey CT. Expanded-capacity adenoviral vectors - the helper-dependent vectors. Mol Med Today 1999; 5: 18-24.
6. Morral N, O'Neal W, Rice K, et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci USA 1999; 96: 12816-12821.
7. Hanahan D, Jessee J, Bloom FR. Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol 1991; 204: 63-113.
8. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
9. Weinberg DH, Keiner G. A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc Natl Acad Sci U S A 1983; 80: 5383-5386.
10. Krougliak V, Graham FL. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum Gene Ther 1995; 6: 1575-1586.
11. Graham FL, Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
12. Hitt M, Bett AJ, Addison C, Prevec L, Graham FL. Techniques for human adenovirus vector construction and characterization. In Methods in Molecular Genetics, Adolph KW (ed.). Academic Press: Orlando, FL, 1995; 13-30.
13. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313: 812-815.
14. Sugden B, Marsh K, Yates J. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol 1985; 5: 410-413.
15. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
16. Doronin KK, Krugliak VA, Grinenko NF, et al. Preparation of a non-defective adenovirus vector based on the Ad5 genome with the E3 region replaced with plasmid DNA with a kanamycin-resistance gene. Mol Gen Mikrobiol Virusol 1993; N1: 31-35.
17. Ding L, Lu S, Batchu R, et al. Bone marrow stromal cells as a vehicle for gene transfer. Gene Ther 1999; 6: 1611-1616.
18. Bett AJ, Prevec L, Graham FL. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 1993; 67: 5911-5921.
19. Bridge E, Ketner G. Redundant control of adenovirus late gene expression by early region 4. J Virol 1989; 63: 631-638.
20. Drinkwater NR, Klinedinst DK. Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency. Proc Natl Acad Sci USA 1986; 83: 3402-3406.
21. Brickell PM, Patel MS. Epstein-Barr virus replication studies and their application to vector design. Mol Biotechnol 1995; 3: 199-205.
22. Nelson JE, Kay MA. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J Virol 1997; 71: 8902-8907.
23. Gilardi P, Stratford L, EgLy JM, Perricaudet M. The two core sequences of the adenovirus E1A inducible E4 promoter are required for the formation of a specific DNA-protein complex. Biochem Biophys Res Commun 1989; 163: 1143-1149.
24. Jones C, Lee KA. E1A-mediated activation of the adenovirus E4 promoter can occur independently of the cellular transcription factor E4F. Mol Cell Biol 1991; 11: 4297-4305.
25. Davidson WF, Giese T, Fredrickson TN. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J Exp Med 1998; 187: 1825-1838.
26. Kapoun AM, Shackleford GM. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wntl transgenic mice. Oncogene 1997; 14: 2985-2989.
27. Shiramizu B, Herndier BG, McGrath MS. Identification of a common clonal human immunodeficiency virus, integration site in human immunodeficiency virus-associated lymphomas. Cancer Res 1994; 54: 2069-2072.
28. Tan BT, Wu L, Berk AJ. An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency. J Virol 1999; 73: 7582-7589.
29. Parks RJ, Chen L, Anton M, et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 1996; 93: 13565-13570.
30. Theodosiou NA, Xu T. Use of FLP/FRT system to study Drosophila development. Methods 1998; 14: 355-365.